surpass 6 tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) A) The SURPASS Program (SURPASS1–6).

Aravamudhan notes

Ischemic optic neuropathy (ION), known colloquially as an eye stroke, can cause sudden vision loss and even blindness

Some patients report that taking their medication before bed means they may experience less discomfort during sleep

Individuals with personal or family history of medullary thyroid carcinoma should not use tirzepatide

Dehydration is a significant contributor to constipation, as it leads to harder, drier stools

Compounded Tirzepatide A dual GIP/GLP-1 medication designed to reduce hunger, improve feelings of fullness, and support significant weight loss through a comprehensive treatment plan